Compare FNLC & LUNG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FNLC | LUNG |
|---|---|---|
| Founded | 1864 | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Industrial Specialties |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 392.2M | 97.1M |
| IPO Year | 1995 | 2020 |
| Metric | FNLC | LUNG |
|---|---|---|
| Price | $33.50 | $1.92 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $3.40 |
| AVG Volume (30 Days) | 26.7K | ★ 255.6K |
| Earning Date | 10-21-2026 | 10-28-2026 |
| Dividend Yield | ★ 4.56% | N/A |
| EPS Growth | ★ 26.34 | 7.64 |
| EPS | ★ 1.65 | N/A |
| Revenue | N/A | ★ $90,497,000.00 |
| Revenue This Year | N/A | $0.06 |
| Revenue Next Year | N/A | $8.58 |
| P/E Ratio | $20.48 | ★ N/A |
| Revenue Growth | N/A | ★ 8.01 |
| 52 Week Low | $24.13 | $1.13 |
| 52 Week High | $36.30 | $2.89 |
| Indicator | FNLC | LUNG |
|---|---|---|
| Relative Strength Index (RSI) | 34.48 | 44.84 |
| Support Level | $32.73 | $1.20 |
| Resistance Level | $36.02 | $2.12 |
| Average True Range (ATR) | 0.87 | 0.10 |
| MACD | -0.19 | -0.01 |
| Stochastic Oscillator | 6.79 | 36.65 |
First Bancorp Inc is a Damariscotta-based bank holding company providing a range of retail and commercial banking services, including deposit accounts and consumer, commercial, and mortgage loans. The company provides investment management and private banking services through an operating division of the bank. Its revenues are generally derived from dividends paid to the company by the bank.
Pulmonx Corp is a commercial-stage medical technology company that provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). solution, which is comprised of the Zephyr Endobronchial Valve (Zephyr Valve), the Chartis Pulmonary Assessment System (Chartis System), and the LungTraX Platform, is designed to treat severe emphysema patients who, despite medical management, are still profoundly symptomatic and either do not want or are ineligible for surgical approaches. The majority of the company's revenue is generated from the provision of cloud hosting and management services. The company geographically, operates in the USA, the EMEA, the Asia Pacific, and other international regions, the majority of revenue from USA.